KEMSA, Pfizer Join Forces to Reinvent Kenya’s Health Supply Chain

Kenya’s quest for a stronger, more reliable health supply chain has received a major boost after the Kenya Medical Supplies Authority (KEMSA) entered high-level talks with global pharmaceutical leader Pfizer.

A Pfizer Accord Supply Chain delegation, led by Accord Access Enabler Lead Anila Gopal, visited the Authority’s Supply Chain Centre, where they were hosted by Mr. Eliud Muriithi, KEMSA’s Director of Commercial Services, representing CEO Dr. Waqo Ejersa, alongside Ministry of Health representative Dr. Nancy Njeru.

Beyond the strategy talks, the Pfizer team toured the facility to experience first-hand the adjustments KEMSA has made to boost operational efficiency including automation of key processes and system upgrades designed to streamline health product distribution.

The discussions focused on closing supply chain gaps, improving last-mile delivery, and harnessing Pfizer’s global expertise to create sustainable, innovative solutions for Kenya’s healthcare system.

“Strategic partnerships like this are critical to ensuring that essential medicines and health products reach every Kenyan, no matter where they live,” said Mr. Muriithi.

Pfizer’s Anila Gopal echoed the sentiment, noting: “We are impressed by the strides KEMSA has made in modernizing its operations. This collaboration presents an exciting opportunity to combine local innovation with Pfizer’s global supply chain expertise to strengthen healthcare delivery in Kenya.”

The engagement underscores KEMSA’s drive to modernize the national health supply chain and its commitment to supporting county governments in delivering universal health coverage.